 | • レポートコード：20QY06-00481 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、PEG化タンパク質のグローバル市場について種類別（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第Viii因子、モノクローナル抗体、その他）、用途別（癌治療、肝炎、慢性腎疾患、白血病、SCID、関節リウマチ・クローン病、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・PEG化タンパク質市場の概要 ・世界の主要地域別PEG化タンパク質市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のPEG化タンパク質市場規模2015-2026：種類別（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第Viii因子、モノクローナル抗体、その他） ・世界のPEG化タンパク質市場規模2015-2026：用途別（癌治療、肝炎、慢性腎疾患、白血病、SCID、関節リウマチ・クローン病、その他） ・PEG化タンパク質の北米市場規模2015-2020 ・PEG化タンパク質のヨーロッパ市場規模2015-2020 ・PEG化タンパク質の中国市場規模2015-2020 ・PEG化タンパク質の日本市場規模2015-2020 ・PEG化タンパク質の東南アジア市場規模2015-2020 ・PEG化タンパク質のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ENZON Pharmaceuticals、Merck Sharp & Dohme、Roche、Pfizer、Amgen、UCB、Crealta (Savient)） ・PEG化タンパク質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・PEG化タンパク質の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global PEGylated Proteins Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global PEGylated Proteins market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the PEGylated Proteins market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the PEGylated Proteins industry.
Based on our recent survey, we have several different scenarios about the PEGylated Proteins YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3487.8 million in 2019. The market size of PEGylated Proteins will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global PEGylated Proteins market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global PEGylated Proteins market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global PEGylated Proteins market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global PEGylated Proteins market. The report also includes nautical information, where it shows PEGylated Proteins market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global PEGylated Proteins market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global PEGylated Proteins market.
The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturers and suppliers lose their bargaining power. Consumers are able to purchase competitor’s products if they are not satisfied with product price or quality. In order for suppliers to tackle the challenge of threat of substitutes, they have to innovate products which meet the needs of their target market segments.
Geographical Analysis:
Based on region, the global PEGylated Proteins market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global PEGylated Proteins market are
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
…
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor Viii
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn’s Disease
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global PEGylated Proteins market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global PEGylated Proteins market.
• The market share of the global PEGylated Proteins market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global PEGylated Proteins market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global PEGylated Proteins market.
1 PEGylated Proteins Market Overview
1.1 PEGylated Proteins Product Scope
1.2 PEGylated Proteins Segment by Type
1.2.1 Global PEGylated Proteins Sales by Type (2020-2026)
1.2.2 Colony Stimulating Factors
1.2.3 Interferons
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor Viii
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 PEGylated Proteins Segment by Application
1.3.1 Global PEGylated Proteins Sales Comparison by Application (2020-2026)
1.3.2 Cancer Treatment
1.3.3 Hepatitis
1.3.4 Chronic Kidney Disease
1.3.5 Leukemia
1.3.6 SCID
1.3.7 Rheumatoid Arthritis & Crohn’s Disease
1.3.8 Others
1.4 PEGylated Proteins Market Estimates and Forecasts (2015-2026)
1.4.1 Global PEGylated Proteins Sales Growth Rate (2015-2026)
1.4.2 Global PEGylated Proteins Revenue and Growth Rate (2015-2026)
1.4.3 Global PEGylated Proteins Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): PEGylated Proteins Industry Impact
1.5.1 How the Covid-19 is Affecting the PEGylated Proteins Industry
1.5.1.1 PEGylated Proteins Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and PEGylated Proteins Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for PEGylated Proteins Players to Combat Covid-19 Impact
2 PEGylated Proteins Estimate and Forecast by Region
2.1 Global PEGylated Proteins Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global PEGylated Proteins Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global PEGylated Proteins Sales Market Share by Region (2015-2020)
2.2.2 Global PEGylated Proteins Revenue Market Share by Region (2015-2020)
2.3 Global PEGylated Proteins Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global PEGylated Proteins Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global PEGylated Proteins Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States PEGylated Proteins Estimates and Projections (2015-2026)
2.4.2 Europe PEGylated Proteins Estimates and Projections (2015-2026)
2.4.3 China PEGylated Proteins Estimates and Projections (2015-2026)
2.4.4 Japan PEGylated Proteins Estimates and Projections (2015-2026)
2.4.5 Southeast Asia PEGylated Proteins Estimates and Projections (2015-2026)
2.4.6 India PEGylated Proteins Estimates and Projections (2015-2026)
3 Global PEGylated Proteins Competition Landscape by Players
3.1 Global Top PEGylated Proteins Players by Sales (2015-2020)
3.2 Global Top PEGylated Proteins Players by Revenue (2015-2020)
3.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PEGylated Proteins as of 2019)
3.4 Global PEGylated Proteins Average Price by Company (2015-2020)
3.5 Manufacturers PEGylated Proteins Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key PEGylated Proteins Players (Opinion Leaders)
4 Global PEGylated Proteins Market Size by Type
4.1 Global PEGylated Proteins Historic Market Review by Type (2015-2020)
4.1.1 Global PEGylated Proteins Sales Market Share by Type (2015-2020)
4.1.2 Global PEGylated Proteins Revenue Market Share by Type (2015-2020)
4.1.3 Global PEGylated Proteins Price by Type (2014-2020)
4.2 Global PEGylated Proteins Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global PEGylated Proteins Sales Forecast by Type (2021-2026)
4.2.2 Global PEGylated Proteins Revenue Forecast by Type (2021-2026)
4.2.3 Global PEGylated Proteins Price Forecast by Type (2021-2026)
5 Global PEGylated Proteins Market Size by Application
5.1 Global PEGylated Proteins Historic Market Review by Application (2015-2020)
5.1.1 Global PEGylated Proteins Sales Market Share by Application (2015-2020)
5.1.2 Global PEGylated Proteins Revenue Market Share by Application (2015-2020)
5.1.3 Global PEGylated Proteins Price by Application (2015-2020)
5.2 Global PEGylated Proteins Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global PEGylated Proteins Sales Forecast by Application (2021-2026)
5.2.2 Global PEGylated Proteins Revenue Forecast by Application (2021-2026)
5.2.3 Global PEGylated Proteins Price Forecast by Application (2021-2026)
3 North America PEGylated Proteins Market Facts & Figures
3.2 North America PEGylated Proteins Sales Market Share by Company (2015-2020)
3.3 North America PEGylated Proteins Sales Market Share by Type (2015-2020)
3.4 North America PEGylated Proteins Sales Market Share by Application (2015-2020)
4 Europe PEGylated Proteins Market Facts & Figures
4.2 Europe PEGylated Proteins Sales Market Share by Company (2015-2020)
4.3 Europe PEGylated Proteins Sales Market Share by Type (2015-2020)
4.4 Europe PEGylated Proteins Sales Market Share by Application (2015-2020)
5 China PEGylated Proteins Market Facts & Figures
5.2 China PEGylated Proteins Sales Market Share by Company (2015-2020)
5.3 China PEGylated Proteins Sales Market Share by Type (2015-2020)
5.4 China PEGylated Proteins Sales Market Share by Application (2015-2020)
6 Japan PEGylated Proteins Market Facts & Figures
6.2 Japan PEGylated Proteins Sales Market Share by Company (2015-2020)
6.3 Japan PEGylated Proteins Sales Market Share by Type (2015-2020)
6.4 Japan PEGylated Proteins Sales Market Share by Application (2015-2020)
7 Southeast Asia PEGylated Proteins Market Facts & Figures
7.2 Southeast Asia PEGylated Proteins Sales Market Share by Company (2015-2020)
7.3 Southeast Asia PEGylated Proteins Sales Market Share by Type (2015-2020)
7.4 Southeast Asia PEGylated Proteins Sales Market Share by Application (2015-2020)
8 India PEGylated Proteins Market Facts & Figures
8.2 India PEGylated Proteins Sales Market Share by Company (2015-2020)
8.3 India PEGylated Proteins Sales Market Share by Type (2015-2020)
8.4 India PEGylated Proteins Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in PEGylated Proteins Business
12.1 ENZON Pharmaceuticals
12.1.1 ENZON Pharmaceuticals PEGylated Proteins Corporation Information
12.1.2 ENZON Pharmaceuticals PEGylated Proteins Business Overview and Total Revenue
12.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.1.4 ENZON Pharmaceuticals PEGylated Proteins Products Offered
12.1.5 ENZON Pharmaceuticals Recent Development
12.2 Merck Sharp & Dohme
12.2.1 Merck Sharp & Dohme PEGylated Proteins Corporation Information
12.2.2 Merck Sharp & Dohme PEGylated Proteins Business Overview and Total Revenue
12.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Sharp & Dohme PEGylated Proteins Products Offered
12.2.5 Merck Sharp & Dohme Recent Development
12.3 Roche
12.3.1 Roche PEGylated Proteins Corporation Information
12.3.2 Roche PEGylated Proteins Business Overview and Total Revenue
12.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche PEGylated Proteins Products Offered
12.3.5 Roche Recent Development
12.4 Pfizer
12.4.1 Pfizer PEGylated Proteins Corporation Information
12.4.2 Pfizer PEGylated Proteins Business Overview and Total Revenue
12.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer PEGylated Proteins Products Offered
12.4.5 Pfizer Recent Development
12.5 Amgen
12.5.1 Amgen PEGylated Proteins Corporation Information
12.5.2 Amgen PEGylated Proteins Business Overview and Total Revenue
12.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen PEGylated Proteins Products Offered
12.5.5 Amgen Recent Development
12.6 UCB
12.6.1 UCB PEGylated Proteins Corporation Information
12.6.2 UCB PEGylated Proteins Business Overview and Total Revenue
12.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.6.4 UCB PEGylated Proteins Products Offered
12.6.5 UCB Recent Development
12.7 Crealta (Savient)
12.7.1 Crealta (Savient) PEGylated Proteins Corporation Information
12.7.2 Crealta (Savient) PEGylated Proteins Business Overview and Total Revenue
12.7.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Crealta (Savient) PEGylated Proteins Products Offered
12.7.5 Crealta (Savient) Recent Development
…
13 PEGylated Proteins Manufacturing Cost Analysis
13.1 PEGylated Proteins Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PEGylated Proteins
13.4 PEGylated Proteins Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PEGylated Proteins Distributors List
14.3 PEGylated Proteins Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global PEGylated Proteins Sales (g) Growth Rate by Type (2020-2026)
Table 2. Global PEGylated Proteins Sales (g) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four PEGylated Proteins Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for PEGylated Proteins Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for PEGylated Proteins Players to Combat Covid-19 Impact
Table 8. Global Market PEGylated Proteins Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global PEGylated Proteins Sales (g) by Region (2015-2020)
Table 10. Global PEGylated Proteins Sales Market Share by Region (2015-2020)
Table 11. Global PEGylated Proteins Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global PEGylated Proteins Revenue Share by Region (2015-2020)
Table 13. Global PEGylated Proteins Sales (g) Forecast by Region (2021-2026)
Table 14. Global PEGylated Proteins Sales Market Share Forecast by Region (2021-2026)
Table 15. Global PEGylated Proteins Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global PEGylated Proteins Revenue Share Forecast by Region (2021-2026)
Table 17. Global PEGylated Proteins (g) of Key Companies (2015-2020)
Table 18. Global PEGylated Proteins Sales Share by Company (2015-2020)
Table 19. Global PEGylated Proteins Revenue (US$ Million) by Company (2015-2020)
Table 20. Global PEGylated Proteins Revenue Share by Company (2015-2020)
Table 21. Global PEGylated Proteins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PEGylated Proteins as of 2019)
Table 22. Global PEGylated Proteins Average Price (USD/mg) of Key Company (2015-2020)
Table 23. Manufacturers PEGylated Proteins Manufacturing Sites and Area Served
Table 24. Manufacturers PEGylated Proteins Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key PEGylated Proteins Players
Table 27. Global PEGylated Proteins Sales (g) by Type (2015-2020)
Table 28. Global PEGylated Proteins Sales Share by Type (2015-2020)
Table 29. Global PEGylated Proteins Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global PEGylated Proteins Price (g) by Type (2015-2020)
Table 31. Global PEGylated Proteins Sales Share by Type (2021-2026)
Table 32. Global PEGylated Proteins Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global PEGylated Proteins Revenue Share by Type (2021-2026)
Table 34. Global PEGylated Proteins Price (g) by Type (2021-2026)
Table 35. Global PEGylated Proteins Sales (g) by Application (2015-2020)
Table 36. Global PEGylated Proteins Sales Share by Application (2015-2020)
Table 37. Global PEGylated Proteins Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global PEGylated Proteins Price (g) by Application (2015-2020)
Table 39. Global PEGylated Proteins Sales (g) by Application (2021-2026)
Table 40. Global PEGylated Proteins Sales Share by Application (2021-2026)
Table 41. Global PEGylated Proteins Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global PEGylated Proteins Revenue Share by Application (2021-2026)
Table 43. Global PEGylated Proteins Price (g) by Application (2021-2026)
Table 44. United States PEGylated Proteins Sales (g) by Company (2015-2020)
Table 45. United States PEGylated Proteins Sales Market Share by Company (2015-2020)
Table 46. United States PEGylated Proteins Sales (g) by Type (2015-2020)
Table 47. United States PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 48. United States PEGylated Proteins Sales (g) by Application (2015-2020)
Table 49. United States PEGylated Proteins Sales Market Share by Application (2015-2020)
Table 50. Europe PEGylated Proteins Sales (g) by Company (2015-2020)
Table 51. Europe PEGylated Proteins Sales Market Share by Company (2015-2020)
Table 52. Europe PEGylated Proteins Sales (g) by Type (2015-2020)
Table 53. Europe PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 54. Europe PEGylated Proteins Sales (g) by Application (2015-2020)
Table 55. Europe PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 56. China PEGylated Proteins Sales (g) by Company (2015-2020)
Table 57. China PEGylated Proteins Sales Market Share by Company (2015-2020)
Table 58. China PEGylated Proteins Sales (g) by Type (2015-2020)
Table 59. China PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 60. China PEGylated Proteins Sales (g) by Application (2015-2020)
Table 61. China PEGylated Proteins Sales Market Share by Application (2015-2020)
Table 62. Japan PEGylated Proteins Sales (g) by Company (2015-2020)
Table 63. Japan PEGylated Proteins Sales Market Share by Company (2015-2020)
Table 64. Japan PEGylated Proteins Sales (g) by Type (2015-2020)
Table 65. Japan PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 66. Japan PEGylated Proteins Sales (g) by Application (2015-2020)
Table 67. Japan PEGylated Proteins Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia PEGylated Proteins Sales (g) by Company (2015-2020)
Table 69. Southeast Asia PEGylated Proteins Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia PEGylated Proteins Sales (g) by Type (2015-2020)
Table 71. Southeast Asia PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia PEGylated Proteins Sales (g) by Type (2015-2020)
Table 73. Southeast Asia PEGylated Proteins Sales Market Share by Application (2015-2020)
Table 74. India PEGylated Proteins Sales (g) by Company (2015-2020)
Table 75. India PEGylated Proteins Sales Market Share by Company (2015-2020)
Table 76. India PEGylated Proteins Sales (g) by Type (2015-2020)
Table 77. India PEGylated Proteins Sales Market Share by Type (2015-2020)
Table 78. India PEGylated Proteins Sales (g) by Application (2015-2020)
Table 79. India PEGylated Proteins Sales Market Share by Application (2015-2020)
Table 80. ENZON Pharmaceuticals Corporation Information
Table 81. ENZON Pharmaceuticals Description and Business Overview
Table 82. ENZON Pharmaceuticals PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. ENZON Pharmaceuticals PEGylated Proteins Product
Table 84. ENZON Pharmaceuticals Recent Development
Table 85. Merck Sharp & Dohme Corporation Information
Table 86. Merck Sharp & Dohme Description and Business Overview
Table 87. Merck Sharp & Dohme PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. Merck Sharp & Dohme PEGylated Proteins Product
Table 89. Merck Sharp & Dohme Recent Development
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. Roche PEGylated Proteins Product
Table 94. Roche Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. Pfizer PEGylated Proteins Product
Table 99. Pfizer Recent Development
Table 100. Amgen Corporation Information
Table 101. Amgen Description and Business Overview
Table 102. Amgen PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. Amgen PEGylated Proteins Product
Table 104. Amgen Recent Development
Table 105. UCB Corporation Information
Table 106. UCB Description and Business Overview
Table 107. UCB PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. UCB PEGylated Proteins Product
Table 109. UCB Recent Development
Table . Crealta (Savient) Corporation Information
Table . Crealta (Savient) Description and Business Overview
Table . Crealta (Savient) PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table . Crealta (Savient) PEGylated Proteins Product
Table . Crealta (Savient) Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. PEGylated Proteins Distributors List
Table 118. PEGylated Proteins Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. PEGylated Proteins Product Picture
Figure 2. Global PEGylated Proteins Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global PEGylated Proteins Market Share by Application in 2020 & 2026
Figure 6. Cancer Treatment Examples
Figure 7. Hepatitis Examples
Figure 8. Chronic Kidney Disease Examples
Figure 9. Leukemia Examples
Figure 10. SCID Examples
Figure 11. Rheumatoid Arthritis & Crohn's Disease Examples
Figure 12. Others Examples
Figure 13. Global PEGylated Proteins Sales (g) Growth Rate (2015-2026)
Figure 14. Global PEGylated Proteins Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global PEGylated Proteins Price Trends Growth Rate (2015-2026) (USD/mg)
Figure 16. Global PEGylated Proteins Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global PEGylated Proteins Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States PEGylated Proteins Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States PEGylated Proteins Sales (g) Growth Rate (2015-2026)
Figure 20. Europe PEGylated Proteins Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe PEGylated Proteins Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China PEGylated Proteins Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China PEGylated Proteins Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan PEGylated Proteins Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan PEGylated Proteins Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia PEGylated Proteins Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia PEGylated Proteins Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India PEGylated Proteins Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India PEGylated Proteins Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest PEGylated Proteins Players Market Share by Revenue in PEGylated Proteins 2015 & 2019
Figure 31. PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global PEGylated Proteins Revenue Share by Type (2015-2020)
Figure 33. Global PEGylated Proteins Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global PEGylated Proteins Revenue Share by Application (2015-2020)
Figure 35. Global PEGylated Proteins Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States PEGylated Proteins Sales Market Share by Type in 2019
Figure 37. United States PEGylated Proteins Sales Market Share by Type in 2019
Figure 38. Europe PEGylated Proteins Sales Market Share by Company in 2019
Figure 39. Europe PEGylated Proteins Sales Market Share by Type in 2019
Figure 40. Europe PEGylated Proteins Sales Market Share by Application in 2019
Figure 41. China PEGylated Proteins Sales Market Share by Company in 2019
Figure 42. China PEGylated Proteins Sales Market Share by Type in 2019
Figure 43. China PEGylated Proteins Sales Market Share by Application in 2019
Figure 44. Japan PEGylated Proteins Sales Market Share by Company in 2019
Figure 45. Japan PEGylated Proteins Sales Market Share by Type in 2019
Figure 46. Japan PEGylated Proteins Sales Market Share by Application in 2019
Figure 47. Southeast Asia PEGylated Proteins Sales Market Share by Company in 2019
Figure 48. Southeast Asia PEGylated Proteins Sales Market Share by Type in 2019
Figure 49. Southeast Asia PEGylated Proteins Sales Market Share by Application in 2019
Figure 50. India PEGylated Proteins Sales Market Share by Company in 2019
Figure 51. India PEGylated Proteins Sales Market Share by Type in 2019
Figure 52. India PEGylated Proteins Sales Market Share by Application in 2019
Figure 53. ENZON Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck Sharp & Dohme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Crealta (Savient) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of PEGylated Proteins
Figure 62. Manufacturing Process Analysis of PEGylated Proteins
Figure 63. PEGylated Proteins Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
飼料脂肪・タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Feed Fats and Proteins Market The global Feed Fats and Proteins market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Feed Fats and Proteins Scope and Market Size The global…- 植物性タンパク質の世界市場レポート2020 Plant-based proteins refer to the proteins of pea, rice, together with those of soybeans. The plant-based proteins market is expected to grow at a rapid growth rate over the forecast period owing to the increasing applications in food and beverage industrials. Market Analysis and Insights: Global Pl…
- タンパク質アミノ酸の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Proteins Amino Acids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proteins Amino Acids mar…
- レンテイン植物タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lentein Plant Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lentein Plant Protein m…
- マリンコラーゲンの世界市場レポート2020 Collagen is a kind of functional protein with the highest content and the widest distribution in mammals. The Asia Pacific region dominated the marine collagen market in 2017. Market Analysis and Insights: Global Marine Collagen Market The global Marine Collagen market was valued at US$ 500.9 millio…